 |
PDBsum entry 6c1v
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
DNA binding protein/DNA
|
PDB id
|
|
|
|
6c1v
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
DNA binding protein/DNA
|
 |
|
Title:
|
 |
Mbd2 in complex with double-stranded DNA
|
|
Structure:
|
 |
Methyl-cpg-binding domain protein 2. Chain: a, b, e, f. Synonym: demethylase,dmtase,methyl-cpg-binding protein mbd2. Engineered: yes. 12-mer DNA. Chain: c, g. Engineered: yes. 12-mer DNA. Chain: d, h.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: mbd2. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Synthetic construct. Organism_taxid: 32630.
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.234
|
R-free:
|
0.268
|
|
|
Authors:
|
 |
M.Lei,W.Tempel,C.H.Arrowsmith,C.Bountra,A.M.Edwards,J.Min,Structural Genomics Consortium (Sgc)
|
|
Key ref:
|
 |
K.Liu
et al.
(2018).
Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
J Biol Chem,
293,
7344-7354.
PubMed id:
|
 |
|
Date:
|
 |
|
05-Jan-18
|
Release date:
|
14-Feb-18
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9UBB5
(MBD2_HUMAN) -
Methyl-CpG-binding domain protein 2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
411 a.a.
68 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
|
|
|
|
|
C-G-G-A-G-T-G-T-A-G-G-C
12 bases
|
|
|
|
G-C-C-T-A-C-A-C-T-C-C-G
12 bases
|
|
|
|
C-G-G-A-G-T-G-T-A-G-G-C
12 bases
|
|
|
|
G-C-C-T-A-C-A-C-T-C-C-G
12 bases
|
|
|
 |
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Biol Chem
293:7344-7354
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
|
|
K.Liu,
C.Xu,
M.Lei,
A.Yang,
P.Loppnau,
T.R.Hughes,
J.Min.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cytosine methylation is a well-characterized epigenetic mark and occurs at both
CG and non-CG sites in DNA. Both methylated CG (mCG)- and mCH (H = A, C, or
T)-containing DNAs, especially mCAC-containing DNAs, are recognized by
methyl-CpG-binding protein 2 (MeCP2) to regulate gene expression in neuron
development. However, the molecular mechanism involved in the binding of
methyl-CpG-binding domain (MBD) of MeCP2 to these different DNA motifs is
unclear. Here, we systematically characterized the DNA-binding selectivities of
the MBD domains in MeCP2 and MBD1-4 with isothermal titration calorimetry-based
binding assays, mutagenesis studies, and X-ray crystallography. We found that
the MBD domains of MeCP2 and MBD1-4 bind mCG-containing DNAs independently of
the sequence identity outside the mCG dinucleotide. Moreover, some MBD domains
bound to both methylated and unmethylated CA dinucleotide-containing DNAs, with
a preference for the CAC sequence motif. We also found that the MBD domains bind
to mCA or nonmethylated CA DNA by recognizing the complementary TG dinucleotide,
which is consistent with an overlooked ligand of MeCP2, i.e. the
matrix/scaffold attachment regions (MARs/SARs) with a consensus sequence of
5'-GGTGT-3' that was identified in early 1990s. Our results also explain why
MeCP2 exhibits similar binding affinity to both mCA- and hmCA-containing dsDNAs.
In summary, our results suggest that in addition to mCG sites, unmethylated CA
or TG sites also serve as DNA-binding sites for MeCP2 and other MBD-containing
proteins. This discovery expands the genome-wide activity of MBD-containing
proteins in gene regulation.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |